Douglas Millar
St George's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Douglas Millar.
Microbiology | 1997
Tim Doran; Mark Tizard; Douglas Millar; Jon Ford; Nazira Sumar; Mark Loughlin; John Hermon-Taylor
The Mycobacterium avium subsp. paratuberculosis (formerly Mycobacterium paratuberculosis) atypical insertion sequence, IS900, encodes a novel gene on the complementary strand to the putative transposase, p43. This gene requires a promoter, ribosome binding site (RBS) and termination codon to be acquired upon insertion into the M. avium subsp. paratuberculosis genome and hence is designated the hed (host expression-dependent) gene of IS900. Analysis of IS900 insertion sites suggests that this element targets translation initiation signals in M. avium subsp. paratuberculosis, specifically inserting between the RBS and start codon of a putative gene sequence. This aligns the hed initiation codon adjacent to a functional RBS and possibly downstream of an active promoter, driving expression of Hed protein. We have confirmed this unique targeting process by detecting expression of hed in M. avium subsp. paratuberculosis at the level of transcription by reverse transcription-PCR. Further, two Hed-specific antibodies detected Hed translation products in Western blots of protein extracts from M. avium subsp. paratuberculosis. A recombinant form of Hed expressed and purified from Escherichia coli will facilitate studies of IS900 transposition and will also be assessed as a diagnostic antigen for M. avium subsp. paratuberculosis disease. Implications of IS900 insertion in M. avium subsp. paratuberculosis pathogenicity are discussed.
Diseases of The Colon & Rectum | 1965
Douglas Millar
SummaryEvidence is provided to show that in three cases of carcinoma associated with colitis, the carcinoma antedated the colitis. The carcinomas were not consequent upon ulcerative colitis. It is suggested that total colectomy is not required in this type of patient because the remainder of the large intestine does not carry the risk of further malignant change as in chronic ulcerative colitis.
British Journal of Surgery | 1965
Peter H. Lord; Douglas Millar
Microbiology | 1998
Mark Tizard; Tim Bull; Douglas Millar; Timothy J. Doran; Helene Martin; Nazira Sumar; Jon Ford; John Hermon-Taylor
The Lancet | 1995
John Hermon-Taylor; Jon Ford; Nazira Sumar; Douglas Millar; Tim Doran; Mark Tizard
Archive | 1996
John Hermon-Taylor; Tim Doran; Douglas Millar; Mark Tizard; Mark Loughlin; Nazira Sumar; John Ford
British Journal of Surgery | 1967
Douglas Millar; Peter H. Lord
British Journal of Surgery | 1961
Douglas Millar
British Journal of Surgery | 1967
Douglas Millar
Archive | 2006
John Hermon-Taylor; Tim Doran; Douglas Millar; Mark Tizard; Mark Loughlin; Nazira Sumar; John Ford
Collaboration
Dive into the Douglas Millar's collaboration.
Commonwealth Scientific and Industrial Research Organisation
View shared research outputs